Clinical Trial Detail

NCT ID NCT03713944
Title Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Big Ten Cancer Research Consortium
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Bevacizumab + Carboplatin + Pemetrexed Disodium

Age Groups: senior adult

No variant requirements are available.